CoreAge Rx vs Contour Health
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Contour Health head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 68 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Contour Health a bad call — it's best for readers seeking pay-per-order care who can confirm vial supply, state eligibility and the prescription refund cutoff. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Contour Health |
|---|---|---|
| Brief Score | 94/100 (A) | 68/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm full vial charge Semaglutide advertised from $30/week; selector says from $25/week. Actual dose and vial size determine full payment. Vial supply descriptions differ; consultations and shipping advertised included. No GLP-1 subscription advertised. Full price detailsCompounded semaglutide offered; complete current selected-vial quote unknown; page advertises $30/week while selector says from $25/week; earlier listing: From $160/mo (starting dose, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm full vial charge Tirzepatide advertised from $50/week; dose and vial size determine upfront payment and supplied weeks. Consultations and shipping advertised included. No GLP-1 subscription advertised; purchased products nonrefundable under general terms. Full price detailsCompounded tirzepatide offered; complete current selected-vial quote unknown; advertised from $50/week, with dose-dependent vial pricing; earlier listing: From $300/mo (starting dose, compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | Advertises forty-six states, excluding Michigan, Mississippi, Kentucky and Arkansas; confirm current licensing for the selected prescription |
| Brand-name access | Not confirmed | Reviewed weight-loss pages describe compounded injections; current branded weight-management access was not established. |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Contour Health: GLP-1 purchases are by vial. Weekly starting figures are estimates; dose, vial size and full charge must be confirmed before payment.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.